Financial News · Live Terminal

Page 147 of 193

Evercore ISI Adjusts Danaher Price Target to $225 From $210, Maintains Outperform Rating

Quest Diagnostics (DGX) has an average rating of overweight and mean price target of $219, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $203.42, Change: $+7.11, Percent Change: +3.62%

$DGX

Australia19d ago

Sprouts Farmers Market to Likely Deliver Relatively In-Line Q1, RBC Says

Sprouts Farmers Market (SFM) is expected to deliver "in-line" Q1 results and reaffirm 2026 forecast, with modestly improving comparable sale trends, RBC Capital Markets said in a report Tuesday.RBC said it raised its Q1 comparable sales estimate to a 1.5% decline from a prior 2% drop, now slightly ahead of consensus expectations, citing improved "transaction data" since mid-February. Adjusted earnings per share are projected to remain at $1.69, roughly in line with Wall Street estimates, as continued investments in pricing and loyalty programs weigh on margins, the firm said.Sprouts Farmers Market is scheduled to release its Q1 financial results on April 29.The brokerage said it expects the company's management to reaffirm its 2026 guidance following the release, noting that quarter-to-date trends have remained "steady" and should support "confidence" in maintaining 2-year stack for Q2 assumptions. Comparable sales for Q2 are forecast in a range of down 2% to flat, broadly aligning with consensus, according to the report.RBC said "primary focus" is expected to be on April comparable sales performance as a key indicator of whether comps can begin to "accelerate" after cycling through tougher year-ago comparisons.RBC has an outperform rating on Sprouts Farmers Market, with an unchanged price target of $114.Price: $74.65, Change: $+0.30, Percent Change: +0.40%

$SFM

Australia19d ago

Arcus Biosciences Has Favorable Setup After Merck Belzutifan Failure, Wedbush Says

Arcus Biosciences (RCUS) shares have a favorable setup following Merck's (MRK) belzutifan phase 3 failure in Litespark-012, with Wedbush Securities saying the readout does not represent negative readthrough for Arcus' casdatifan and highlights a differentiated profile in clear cell renal cell carcinoma, or RCC.The brokerage said in a Tuesday note that the Merck data do not impact Arcus' TKI-free frontline strategy and that casdatifan remains supported by a more optimal development approach and stronger comparative efficacy versus belzutifan.Wedbush also said recent weakness following the discontinuation of Arcus' domvanalimab program has created an attractive entry point ahead of upcoming clinical data readouts, reinforcing a favorable setup for the stock.The firm reiterated its outperform rating on the stock and price target of $41 per share.Price: $23.31, Change: $+0.57, Percent Change: +2.51%

$MRK$RCUS

Australia19d ago

JPMorgan Cuts Price Target on Danaher to $245 From $275, Maintains Overweight Rating

Danaher (DHR) has an average rating of Buy and mean price target of $254.19, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $191.43, Change: $-4.07, Percent Change: -2.08%

$DHR

Australia19d ago

Deutsche Telekom Said to Consider Full Combination With T-Mobile US, Bloomberg Reports

Price: $203.99, Change: $+5.63, Percent Change: +2.84%

$TMUS

Australia19d ago

Jefferies Adjusts Price Target on Danaher to $245 From $240, Maintains Buy Rating

$DHR

Australia19d ago

Donnelley Financial Solutions Board Authorizes $150 Million Share Buyback Program

Donnelley Financial Solutions (DFIN) said in a regulatory filing Tuesday that on April 16, the company's board approved a new share buyback program of up to $150 million of common stock.The company said the program began on April 17, and will be effective through Dec. 31, 2027, adding that it replaces the prior $150 million program, which had about $15 million left unused.The company said it may repurchase shares on the open market or through private transactions, and the timing and amount will depend on market conditions and other factors.The company added it may also use a Rule 10b5-1 plan to allow repurchases during periods when it might otherwise be restricted from trading. The program can be suspended or discontinued at any time.Shares of Donnelley Financial Solutions were up 1.5% in the session.Price: $53.33, Change: $+0.80, Percent Change: +1.52%

$DFIN

Australia19d ago

Perpetuals.com's BayesShield AI Platform to Be Deployed Across German UDS Research Centers

Perpetuals.com (PDC) has entered into a licensing agreement with the German University of Digital Science to integrate its BayesShield AI predictive intelligence platform across the university's research centers and digital learning infrastructure, the university said Tuesday.Under the agreement, German UDS said it will deploy BayesShield AI within its Research Center for Artificial Intelligence, Research Center for Cybersecurity, and Research Center for Digital Transformations.Students and faculty will use BayesShield's AI models to analyze real-world trading patterns, conduct research on retail investor behavior, and develop risk management frameworks, the university said.The university also said its six research centers will help advance BayesShield's machine learning models and publish research output in peer-reviewed journals.Shares of Perpetuals.com fell more than 12% in Tuesday trading.Price: $6.92, Change: $-0.96, Percent Change: -12.18%

$PDC

Australia19d ago

Jefferies Raises Quest Diagnostics Price Target to $225 From $220

$DGX

Australia19d ago

Truist Securities Cuts Tractor Supply Price Target to $44 From $55, Hold Rating Kept

Tractor Supply (TSCO) has an average rating of overweight and mean price target of $56.19, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $39.92, Change: $-4.90, Percent Change: -10.92%

$TSCO

Australia19d ago

Apple's Incoming CEO Faces Crucial AI Test, Wedbush Says

Apple's (AAPL) incoming CEO, John Ternus, needs to get the company's AI strategy right and sharpen its approach to turning that technology into new revenue streams, Wedbush Securities said Tuesday in a report.Apple's software and services growth depends on its "unrivaled" installed base, and innovation around foldable devices, an AI-enabled iPhone, and more affordable Apple Glasses will be central to the company's next chapter, the report said.Ternus is expected to bring in more outside innovation, and a shift away from Apple's historically cautious stance on mergers and acquisitions will be important, Wedbush said."Apple has more cash, consumers, and brand recognition than any company in theworld," the report said. "Now is the time to flex the muscles and go on the offensive instead of the defensive."Tim Cook is stepping down as CEO and will become executive chairman, effective Sept. 1. Ternus currently is senior vice president of hardware engineering.Wedbush maintained its outperform rating on Apple stock with a $350 price target.Price: $266.22, Change: $-6.83, Percent Change: -2.50%

$AAPL

Australia19d ago

Erasca Says Phase 1 Data Readout for ERAS-0015 Expected in May

Erasca (ERAS) said in a filing Tuesday that it has narrowed the timeline for the data readout of its phase 1 trials evaluating its pan-RAS molecular glue ERAS-0015 to not later than mid-May, compared with prior guidance of H1.The company is evaluating ERAS-0015 in a phase 1 trial in patients with RAS-mutant solid tumors, while its licensor Guangzhou Joyo Pharmatech is evaluating ERAS-0015 in patients with advanced solid tumors harboring specific RAS mutations in China, according to a filing with the US Securities and Exchange Commission.Shares of Erasca were up 3.9% in Tuesday trading.Price: $22.55, Change: $+0.84, Percent Change: +3.87%

$ERAS

Australia19d ago

Kemper Completes Sale of Newins Distribution Operation to Confie

Kemper (KMPR) said Tuesday that it has completed its sale of Newins property and casualty distribution operations to Confie.The transaction includes the sale of Newins Insurance Agency, which operates under the Illinois Vehicle, A-Abana, and Access Auto Insurance brands in a limited number of states, the company said.Shares of the company were down 1.7% in Tuesday trading.Price: $33.11, Change: $-0.44, Percent Change: -1.31%

$KMPR

Australia19d ago

Intel Poised for 'Slight Beat' Amid Solid Server CPU Demand, RBC Says

Intel (INTC) is expected to report a "slight beat" in its fiscal first-quarter results amid robust server central processing unit demand, RBC Capital Markets said in a note e-mailed Tuesday.On Thursday, the chipmaker is likely to post adjusted per-share earnings and revenue above RBC's projections for breakeven and $12.20 billion, respectively, for the March quarter, according to the brokerage. The current consensus on FactSet is for non-GAAP EPS of $0.02 and sales of $12.42 billion."We expect a slight beat/raise driven by strong server CPU demand," RBC analyst Srini Pajjuri said. "(Personal computer) market also appears to be holding up for now."First-quarter revenue in the company's data center and artificial intelligence segment is pegged at $4.3 billion, representing a 3% annual gain, with room for potential upside, according to RBC."While demand remains strong, management expected internal wafer supply constraints to be most acute in (the first quarter) which could limit near-term upside," Pajjuri wrote. "Recent media reports point to Intel raising prices which should help."For the current quarter, RBC expects Intel to issue an outlook above Wall Street's estimates of $13.1 billion in revenue and adjusted EPS of $0.09, driven by server CPU demand and improving wafer supply.The data center and AI business is projected to see sequential growth of 10% in the second quarter, with RBC seeing potential upside amid improving supply and healthy pricing. The brokerage expects server demand to continue to benefit from agentic AI and sees industry supply remaining "tight" through 2026, it said in the note.RBC maintained its sector perform rating on Intel's stock with a $48 price target.The company's shares were up 0.3% in Tuesday afternoon trade, bringing its year-to-gains to nearly 79%.Last year, the US government agreed to invest $8.9 billion in Intel's common stock as part of a deal to secure a stake in the company. Separately, Nvidia (NVDA) agreed to inject $5 billion in Intel under a collaboration that aims to develop new data center and PC chips.Price: $66.04, Change: $+0.34, Percent Change: +0.52%

$INTC$NVDA

Australia19d ago

Scholastic Reports Preliminary Results of Dutch Auction Tender Offer

Scholastic (SCHL) on Tuesday announced preliminary results from its modified Dutch auction tender offer, which closed on Monday.The company said that shareholders tendered a total of about 2.85 million shares at or below the $40 per share purchase price, including about 1 million shares that were tendered by notice of guaranteed delivery.Based on the preliminary count, Scholastic expects to purchase all properly tendered shares at $40 each, for a total cost of about $114.1 million, excluding fees and expenses, it added.The company said that following completion of the offer, it expects nearly 17.9 million shares to remain outstanding, representing a reduction of about 13.7% in its share count.Shares of Scholastic rose 2.3% in the session.Price: $40.69, Change: $+0.93, Percent Change: +2.34%

$SCHL

Australia19d ago

Top Midday Gainers

Electro-Sensors (ELSE) agreed to be acquired by steute Technologies for $7.75 a share, a premium of about 75% to the closing price on Monday.The stock surged 72% as intraday volume topped 361,700 shares versus the daily average of 2,909.UnitedHealth Group (UNH) raised its full-year earnings outlook after the health insurance giant recorded an unexpected increase in Q1 results.The stock rose 8.4% as volume topped 17.6 million shares versus the daily average of 10 million.Aevex's (AVEX) director Brian Raduenz purchased 50,000 shares of the company for $1 million on April 16.The stock advanced 7.5% as volume topped 4.5 million shares versus the daily average of 15.8 million.Price: $7.62, Change: $+3.19, Percent Change: +72.16%

$AVEX$ELSE$UNH

Australia19d ago

Market Chatter: Coinbase Global, Gemini Titan Sued by New York for Prediction Markets Allegedly Being Illegal Gambling

Coinbase Global (COIN) and Gemini Titan have been sued by New York Attorney General Letitia James for allegedly violating the state laws against against illegal gambling with their prediction markets, Reuters reported Tuesday, citing complaints filed in a state court in Manhattan.James said that the two companies neglected to obtain licenses from the New York State Gaming Commission for the markets, which fit under the state's definition of gambling, according to the report. The attorney general added the two companies also allowed 18- to 20-year-olds use their platforms, going against the state's minimum age of 21 for mobile sports betting, the report said.James aims to recoup illegal profits, impose civil penalties triple of the amount, and provide restitution to customers, as well as to ban Coinbase and Gemini from allowing people under 21 to wager, the report said.Coinbase and Gemini Titan did not immediately reply to a request for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $201.15, Change: $-10.48, Percent Change: -4.95%

$COIN

Australia19d ago

Restaurant Brands Seen Extending Q1 Momentum on Burger King, International Strength, RBC Says

Restaurant Brands International (QSR) is expected to extend its "positive momentum" into Q1, led by strength at Burger King and its international segment, while valuation leaves room for further upside, RBC Capital Markets said.The brokerage said in a Monday note that it expects the company to "beat" quarterly estimates and said risk/reward and investor sentiment remain positive. It cited improving fundamentals and a high-teens discount to mature global quick-service peers.Burger King is gaining traction as ongoing renovations, menu innovation and targeted marketing drive performance, with only about 58% of US locations modernized by the end of 2025.RBC said the brand is approaching a "critical mass" of renovated stores that is creating a positive halo effect on performance. International operations remain a standout, with broad-based strength across key European markets such as France, the UK, Spain and Germany.The firm flagged potential headwinds at Tim Hortons from slowing Canadian population growth, which could limit same-store sales upside in 2026. Popeyes is still undergoing an operational turnaround that may take multiple quarters before returning to positive same-store sales growth.RBC said it continues to view Restaurant Brands International as a "top idea" in the global franchised fast-food sector, with improving Burger King US trends, accelerating international growth and a shift toward growth-focused capital allocation expected to support the stock.The firm has an outperform rating on Restaurant Brands and raised its price target to $90 from $83.Price: $78.71, Change: $-0.20, Percent Change: -0.25%

$QSR

Australia19d ago

CrowdStrike to Benefit From Higher Cybersecurity Spend, KeyBanc Says

CrowdStrike (CRWD) is positioned to benefit from accelerating cybersecurity spending driven by disruption fears stemming from Anthropic's restricted-access advanced Claude Mythos model, KeyBanc said in a Monday research note.KeyBanc sees CrowdStrike's core runtime protection abilities as the "enduring mission-critical function" for protection against attacks should a Mythos-like model becomes generally available, according to the note.The company's Falcon platform is well-positioned with many sectors of spending that are likely to be prioritized in expectation of risks posed by Mythos, analysts wrote.The company is a partner in Anthropic's Project Glasswing designed to test Mythos against cyber threats, which is expected to offer an incremental competitive advantage, KeyBanc stated.The brokerage said it upgraded the stock to overweight from sector weight and set a price target of $525 per share.Price: $452.77, Change: $+19.62, Percent Change: +4.53%

$CRWD

Australia19d ago

Top Midday Decliners

Spruce Biosciences (SPRB) reported overnight that it priced a $60 million public offering of its common shares and pre-funded warrants.Shares sank 24% following an increase in intraday trading volume to over 472,000 from a daily average of about 46,000.Tractor Supply's (TSCO) Q1 results disappointed, with EPS missing consensus and revenue below the consensus estimate.Shares slumped 10% as intraday trading volume climbed to more than 15 million from a daily average of about 6.76 million.Washington Trust Bancorp (WASH) reported late Monday a year-over-year decline in Q1 revenue that also trailed analysts' estimates.Shares declined 16% as intraday trading volume rose to over 381,000 from a daily average of about 166,000.Price: $52.85, Change: $-17.05, Percent Change: -24.39%

$SPRB$TSCO$WASH

Showing 2921-2940 of 3847

Australia19d ago

Intel Poised for 'Slight Beat' Amid Solid Server CPU Demand, RBC Says

$INTC$NVDA